Skip to main content
. 2011 Aug 15;6(8):e23158. doi: 10.1371/journal.pone.0023158

Table 3. Incremental cost-effectiveness of a subset of diagnostic procedures for Pneumocystis pneumonia, assuming 50% disease prevalence.

Specimen collection and diagnostic procedure % of patients successfully treated Average cost per life-year gained Cost per additional life-year gained, compared with next-least-effective procedure
IS/TBO 0.68 $25 $N/A
ES/nPCR 0.82 $28 $43
ES/rtPCR 0.83 $36 $804
IS/PCR 0.85 $39 $156
IS/nPCR 0.90 $40 $60

IS: Induced sputum; ES: expectorated sputum; TBO: Toluidine Blue O; PCR: polymerase chain reaction; nPCR: nested PCR; rtPCR: real-time (quantitative) PCR.